KIDNEY-SPARING

Clinical trials for KIDNEY-SPARING explained in plain language.

Never miss a new study

Get alerted when new KIDNEY-SPARING trials appear

Sign up with your email to follow new studies for KIDNEY-SPARING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to save kidneys in pelvic cancer patients

Disease control Recruiting now

This phase II trial tests whether a combination of tislelizumab (an immunotherapy) and nab-paclitaxel (a chemotherapy drug) can treat renal pelvic cancer while allowing patients to keep their kidney. About 35 adults with early-stage cancer will receive the drugs, and if the tumor…

Matched conditions: KIDNEY-SPARING

Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

KIDNEY-SPARING

Get alerted when new KIDNEY-SPARING trials appear

New drug combo aims to save kidneys in pelvic cancer patients